IOTA Pharmaceuticals


IOTA Pharmaceuticals
Fragment - based Drug Discovery
GBM Drug Bank
Glioma & Glioblastoma
WINDOW on Glioblastoma
IOTA Pharmaceuticals
May 22, 2018

IOTA hosts BBSRC student

Cambridge University Department of Pharmacology PhD student, Matthew Harris, has completed a three month placement at IOTA Pharmaceuticals reviewing the patent landscape of glioblastoma. Based on this work, Matt has generated a detailed overview that has been accepted for publication in Expert Opinion on Therapeutic Patents.

We wish Matt all the best for the future.

Pictured below, Matt Harris (middle) together with his PhD supervisor, Dr Graham Ladds (left) and IOTA CEO, Dr David Bailey (right).